HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

G Valesini Selected Research

Adalimumab (Humira)

9/2009Nucleosome accumulation and reduction of C-reactive protein are associated with the generation of anti-nuclear antibodies in patients with rheumatoid arthritis treated with adalimumab, but not with etanercept.
1/2007Appearance of rheumatoid nodules following anti-tumor necrosis factor alpha treatment with adalimumab for rheumatoid arthritis.
11/2006Power Doppler sonography monitoring of synovial perfusion at the wrist joints in patients with rheumatoid arthritis treated with adalimumab.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


G Valesini Research Topics

Disease

27Rheumatoid Arthritis
01/2018 - 07/2000
18Systemic Lupus Erythematosus (Libman-Sacks Disease)
01/2020 - 01/2000
14Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2019 - 11/2000
9Psoriatic Arthritis
02/2015 - 02/2002
8Rheumatic Diseases (Rheumatism)
01/2012 - 03/2002
7Infections
12/2018 - 04/2005
7Pain (Aches)
01/2012 - 07/2006
6Autoimmune Diseases (Autoimmune Disease)
05/2016 - 03/2002
6Systemic Scleroderma (Systemic Sclerosis)
03/2015 - 05/2003
5Thrombosis (Thrombus)
01/2019 - 01/2000
5Osteoarthritis
03/2010 - 02/2002
4Inflammation (Inflammations)
02/2015 - 01/2009
4Arthritis (Polyarthritis)
02/2015 - 05/2007
4Necrosis
06/2014 - 08/2002
4Fibromyalgia (Fibrositis)
11/2010 - 09/2009
3Adult-Onset Still's Disease
12/2014 - 09/2008
3Tuberculosis (Tuberculoses)
06/2014 - 01/2008
3Ankylosing Spondylitis
03/2010 - 09/2002
3Fever (Fevers)
03/2006 - 07/2000
2Joint Diseases (Joint Disease)
01/2018 - 02/2002
2Lymphoma (Lymphomas)
03/2015 - 01/2015
2Vasculitis (Vasculitides)
01/2015 - 09/2010
2Sjogren's Syndrome (Sjogren Syndrome)
06/2014 - 11/2010
2Rheumatic Heart Disease (Rheumatic Heart Diseases)
09/2013 - 09/2010
2Type 1 Diabetes Mellitus (Autoimmune Diabetes)
12/2010 - 07/2004
2Atherosclerotic Plaque (Atheroma)
07/2010 - 01/2010
2Carotid Artery Diseases
01/2010 - 07/2004
2Gout
01/2010 - 07/2007
2Atherosclerosis
01/2010 - 07/2004
2Hypertension (High Blood Pressure)
03/2009 - 11/2008
2Psoriasis (Pustulosis Palmaris et Plantaris)
11/2007 - 01/2005
2Crohn Disease (Crohn's Disease)
11/2007 - 01/2005
1Thrombocytopenia (Thrombopenia)
01/2019
1Sacroiliitis
12/2018
1Lupus Nephritis
09/2018
1Macular Degeneration (Age-Related Maculopathy)
09/2018
1Toxic Optic Neuropathy
09/2018
1Discoid Lupus Erythematosus
09/2018
1Habitual Abortion (Recurrent Miscarriage)
05/2016
1Venous Thrombosis (Deep-Vein Thrombosis)
05/2016
1Hypoxia (Hypoxemia)
03/2015
1Spinal Cord Injuries (Spinal Cord Injury)
03/2015
1Pulmonary Arterial Hypertension
03/2015
1Vascular Diseases (Vascular Disease)
03/2015
1Ulcer
03/2015

Drug/Important Bio-Agent (IBA)

27AntibodiesIBA
01/2019 - 01/2000
12Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2013 - 08/2002
11CytokinesIBA
03/2015 - 02/2002
8Proteins (Proteins, Gene)FDA Link
01/2018 - 05/2000
7AutoantibodiesIBA
01/2020 - 03/2002
7Antiphospholipid AntibodiesIBA
06/2016 - 11/2000
6Biomarkers (Surrogate Marker)IBA
01/2018 - 04/2010
6Immunoglobulin G (IgG)IBA
02/2015 - 07/2004
6Biological ProductsIBA
01/2015 - 01/2005
5Phospholipids (Phosphatides)FDA LinkGeneric
05/2016 - 01/2000
5AntigensIBA
09/2013 - 05/2000
5Antirheumatic Agents (DMARD)IBA
01/2012 - 10/2004
5Infliximab (Remicade)FDA Link
12/2008 - 08/2002
5Interleukin-13IBA
05/2003 - 02/2002
4Rheumatoid FactorIBA
01/2018 - 10/2004
4EnzymesIBA
05/2016 - 07/2004
4InterleukinsIBA
02/2015 - 02/2002
4ametantrone (HAQ)IBA
11/2010 - 07/2006
4Cardiolipins (Cardiolipin)IBA
09/2010 - 11/2000
4Interleukin-12 (IL 12)IBA
05/2003 - 02/2002
3Pharmaceutical PreparationsIBA
09/2018 - 09/2002
3GlucocorticoidsIBA
06/2016 - 01/2008
3ImmunosorbentsIBA
05/2016 - 04/2005
3Anti-Citrullinated Protein AntibodiesIBA
11/2015 - 10/2004
3Peptides (Polypeptides)IBA
02/2015 - 04/2006
3VaccinesIBA
06/2014 - 03/2011
3anti-endothelial cell antibodyIBA
09/2013 - 11/2008
3C-Reactive ProteinIBA
01/2012 - 07/2006
3AutoantigensIBA
01/2010 - 07/2004
3Etanercept (Enbrel)FDA Link
09/2009 - 07/2006
3Adalimumab (Humira)FDA Link
09/2009 - 11/2006
3Methotrexate (Mexate)FDA LinkGeneric
11/2008 - 10/2004
2Thromboplastin (Tissue Factor)IBA
01/2019 - 06/2003
2Glycoproteins (Glycoprotein)IBA
05/2016 - 04/2005
2Complement System Proteins (Complement)IBA
03/2015 - 03/2006
2Interleukin-10 (Interleukin 10)IBA
02/2015 - 04/2010
2Immunomodulating AgentsIBA
04/2011 - 07/2010
2Rituximab (Mabthera)FDA Link
04/2011 - 03/2005
2Neuropeptide YIBA
04/2010 - 09/2009
2Hormones (Hormone)IBA
04/2010 - 01/2009
2beta 2-Glycoprotein I (Apolipoprotein H)IBA
01/2010 - 05/2003
2Anticardiolipin AntibodiesIBA
03/2009 - 05/2003
2Interleukin-18 (Interleukin 18)IBA
03/2009 - 08/2002
2Adrenal Cortex Hormones (Corticosteroids)IBA
04/2004 - 07/2000
2Prothrombin (Factor II)IBA
05/2003 - 05/2000
2Annexin A5IBA
05/2003 - 05/2000
1Protein Isoforms (Isoforms)IBA
04/2019
1Anti-Bacterial Agents (Antibiotics)IBA
12/2018
1Retinaldehyde (Retinal)IBA
09/2018
1Antimalarials (Antimalarial Agents)IBA
09/2018
1Anti-Idiotypic AntibodiesIBA
11/2015
1Intercellular Signaling Peptides and Proteins (Growth Factors)IBA
03/2015
1Macrophage Migration-Inhibitory FactorsIBA
03/2015

Therapy/Procedure

15Therapeutics
12/2018 - 01/2000
2Mud Therapy (Mud Bath)
01/2009 - 01/2009